TRAF6 and colorectal carcinoma: Overexpression of E3 ligase TRIM25 also promotes oxaliplatin resistance and the stem cell properties in CRC by blocking the K63-linked ubiquitination and degradation of EZH2 mediated by E3 ligase TNF receptor-associated factor 6 (TRAF6) [29].